JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 1, 2003; DOI: 10.1124/jpet.103.051086


0022-3565/03/3062-498-504$20.00
JPET 306:498-504, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.051086v1
306/2/498    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, X.
Right arrow Articles by Priestley, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, X.
Right arrow Articles by Priestley, T.

NEUROPHARMACOLOGY

Vinpocetine Is a Potent Blocker of Rat NaV1.8 Tetrodotoxin-Resistant Sodium Channels

Xiaoping Zhou, Xiao-Wei Dong, James Crona, Maureen Maguire, and Tony Priestley

CNS/CV Biological Research, Schering-Plough Research Institute, Kenilworth, New Jersey

Vinpocetine is a clinically used synthetic vincamine derivative with a diverse pharmacological profile that includes action at several ion channels, principally "generic" populations of sodium channels that give rise to tetrodotoxin-sensitive conductances. A number of cell types are known to express tetrodotoxin-resistant (TTXr) sodium conductances, the molecular bases of which have remained elusive until recently. One such TTXr channel, termed NaV1.8, is of particular interest because of its prominent and selective expression in peripheral afferent nerves. The effects of vinpocetine on TTXr channels specifically, are unknown. We have assessed the effects of the drug on cloned rat NaV1.8 channels expressed in a dorsal root ganglion-derived cell line, ND7/23. Vinpocetine produced a concentration- and state-dependent inhibition of NaV1.8 sodium channel activity. Voltage-clamp experiments revealed an ~3-fold increase in vinpocetine potency when whole-cell NaV1.8 conductances were elicited from relatively depolarized potentials (–35 mV; IC50 = 3.5 µM) compared with hyperpolarized holding potentials (–90 mV; IC50 = 10.4 µM). Vinpocetine also produced an ~22 mV leftward shift in the voltage dependence of NaV1.8 channel inactivation but did not affect the voltage range of channel activation. These properties are reminiscent of several other known sodium channel blockers and suggested that vinpocetine may exhibit frequency-dependent block. Accordingly, tonic block of NaV1.8 channels by vinpocetine (3 µM) increased proportionally with increasing depolarizing commands over the frequency range 0.1 to 1Hz. In summary, the present data demonstrate that vinpocetine is capable of blocking NaV1.8 sodium channel activity and suggest a potential additional utility in various sensory abnormalities arising from abnormal peripheral nerve activity.


Received for publication February 28, 2003
Accepted April 22, 2003.

Address correspondence to: Dr. Tony Priestley, CNS/CV Biological Research, Schering-Plough Research Institute, 2015 Galloping Hill Rd., Kenilworth, NJ 07033. E-mail: tony.priestley{at}spcorp.com




This article has been cited by other articles:


Home page
J. Neurosci.Home page
L. M. Sharkey, X. Cheng, V. Drews, D. A. Buchner, J. M. Jones, M. J. Justice, S. G. Waxman, S. D. Dib-Hajj, and M. H. Meisler
The ataxia3 Mutation in the N-Terminal Cytoplasmic Domain of Sodium Channel Nav1.6 Disrupts Intracellular Trafficking
J. Neurosci., March 4, 2009; 29(9): 2733 - 2741.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Seda, F. M Pinto, S. Wray, C. G Cintado, P. Noheda, H. Buschmann, and L. Candenas
Functional and Molecular Characterization of Voltage-Gated Sodium Channels in Uteri from Nonpregnant Rats
Biol Reprod, November 1, 2007; 77(5): 855 - 863.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. Zhao, R. Ziane, A. Chatelier, M. E. O'Leary, and M. Chahine
Lidocaine Promotes the Trafficking and Functional Expression of Nav1.8 Sodium Channels in Mammalian Cells
J Neurophysiol, July 1, 2007; 98(1): 467 - 477.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. E. Medina, T. E. Krahe, and A. S. Ramoa
Restoration of Neuronal Plasticity by a Phosphodiesterase Type 1 Inhibitor in a Model of Fetal Alcohol Exposure
J. Neurosci., January 18, 2006; 26(3): 1057 - 1060.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. J. Devaux and S. S. Scherer
Altered Ion Channels in an Animal Model of Charcot-Marie-Tooth Disease Type IA
J. Neurosci., February 9, 2005; 25(6): 1470 - 1480.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. K. Wittmack, A. M. Rush, M. J. Craner, M. Goldfarb, S. G. Waxman, and S. D. Dib-Hajj
Fibroblast Growth Factor Homologous Factor 2B: Association with Nav1.6 and Selective Colocalization at Nodes of Ranvier of Dorsal Root Axons
J. Neurosci., July 28, 2004; 24(30): 6765 - 6775.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.